Sale of its global ophthalmology business


Our attorneys represented Pfizer in connection with the sale of its surgical ophthalmology business to Advanced Medical Optics (AMO). AMO acquired the surgical business for US$450 million, including the Healon® line of viscoelastic products used in ocular surgery, CeeOn® and Tecnis® intraocular lenses (IOL) used in cataract surgery and the Baerveldt® glaucoma shunt. Antitrust clearances were required from several national competition authorities in and outside Europe.

Email Disclaimer